explore -WSS

explore

author：hotspot 2025-08-11 11:46:07 - browse：8587

Adam Feuerstein, upper left, moderated a panel with, clockwise, David Chang of Allogene Therapeutics, Rachel Haurwitz of Caribou Biosciences, and Lynelle Hoch of Bristol Myers Squibb. STAT

If you ask biopharma leaders what’s ahead for CAR-T cancer therapy, they say the future is bright. And that future will also look markedly different than it does today, three of them said at the STAT 2023 Future Summit on Wednesday.

Now in its second decade, the cell therapy — which attacks cancer by extracting white blood cells from a patient, genetically modifying them, and then re-infusing them to fight the cancer — has made remarkable strides. Biotech reporter Adam Feuerstein reminded panelists that Emily Whitehead, the first pediatric patient to receive the therapy at age 10, has just started college.

But for all its success in changing the lives of up to 7,000 patients to the point one can use the word “cure,” the field has been hampered by wait lists at manufacturers making these patient-specific, autologous therapies and a shortage of medical centers to administer them. Patients bear a burden, too: Training their B cells to attack their tumors requires an onerous depletion process before their cells can be taken out of their bodies.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Moonlake's readout produced a cash windfall. Risks remain
Next article： Should insurance cover cosmetic surgery?

leisure time

entertainment

WSS

Beyond aggravation: Constipation is an American epidemic

Some medical students still think black patients feel less pain

Decentralized clinical trials need collaboration to achieve wider use

Ozempic cut risk of death in diabetes patients with chronic kidney disease

J&J reports mixed data on next

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Wikipedia

explore

hotspot

Moonlake's readout produced a cash windfall. Risks remain

Asbestos ban is immediate, but health effects will linger for decades

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

'Patient friction coefficient' can gauge a clinical trial's patient burden

Activists slam private health insurers over coverage restrictions

U.K. officials, researchers try to ease path for bespoke genetic treatments

Tori Bowie and the unacceptable rates of Black maternal death

Stroke rates rising, especially in working

In Memoriam: Notable people who died in 2023

Hospitals need to get ahead of regulations on climate change

hotspot

Bubonic plague hit France in 1720. Officials dithered. Sound familiar?

Beyond aggravation: Constipation is an American epidemic

Beyond aggravation: Constipation is an American epidemic

Duchenne drug from Nippon Shinyaku fails in rare confirmatory trial

Chinese researcher claims birth of first gene

Feng Zhang suggests Editas didn’t move quickly enough to find product targets

leisure time

entertainment

focus

leisure time